Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$245M |
| 2 |
KeyCorp
KEY
|
+$199M |
| 3 |
RTX Corp
RTX
|
+$183M |
| 4 |
EMC
EMC CORPORATION
EMC
|
+$170M |
| 5 |
Ralph Lauren
RL
|
+$167M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$245M |
| 2 |
US Bancorp
USB
|
+$216M |
| 3 |
Apple
AAPL
|
+$207M |
| 4 |
Visa
V
|
+$188M |
| 5 |
Bank of America
BAC
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 44.36% |
| 2 | Financials | 9.66% |
| 3 | Consumer Discretionary | 8.08% |
| 4 | Energy | 7.72% |
| 5 | Technology | 6.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
FNFG
401
DELISTED
FIRST NIAGARA FINANCIAL GROUP INC
FNFG
| $37M | 0.06% |
3,572,570
+1,811,360
| +103% | +$18.8M |
2013 Q2
1 quarter
|
|
|
CFN
402
DELISTED
CAREFUSION CORPORATION
CFN
| $37M | 0.06% |
1,002,593
-196,728
| -16% | -$7.34M |
2013 Q2
1 quarter
|
|
403
Bank of Hawaii
BOH
$2.71B
| $36.7M | 0.06% |
673,194
+672,994
| +336,497% | +$36.3M |
2013 Q2
1 quarter
|
|
|
QLGC
404
DELISTED
QLOGIC CORP
QLGC
| $36.6M | 0.06% |
3,346,400
-905,225
| -21% | -$9.96M |
2013 Q2
1 quarter
|
|
|
RAD
405
DELISTED
Rite Aid Corporation
RAD
| $36.6M | 0.06% |
384,046
+315,231
| +458% | +$21.5M |
2013 Q2
1 quarter
|
|
|
MTCN
406
DELISTED
ARCELORMITTAL 6% MANDATORILTY CONV SUB NT DUE 2016 (LUX)
MTCN
| $36.5M | 0.06% |
1,700,006
+6
| +0% | +$127 |
2013 Q2
1 quarter
|
|
|
QLIK
407
DELISTED
QLIK TECHNOLOGIES INC COM STK (DE)
QLIK
| $36.4M | 0.06% |
1,063,429
+1,024,235
| +2,613% | +$33.6M |
2013 Q2
1 quarter
|
|
408
Mondelez International
MDLZ
$73.7B
| $36.4M | 0.06% |
1,157,247
-2,149,983
| -65% | -$66.7M |
2013 Q2
1 quarter
|
|
409
CALL
First Solar
FSLR
$18.5B
| $36.4M | 0.06% |
904,200
+319,800
| +55% | +$13.5M |
2013 Q2
1 quarter
|
|
|
POT
410
DELISTED
Potash Corp Of Saskatchewan
POT
| $36.3M | 0.06% |
1,162,016
+1,000,767
| +621% | +$33.2M |
2013 Q2
1 quarter
|
|
|
CBST
411
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
| $36.3M | 0.06% |
571,654
+421,739
| +281% | +$25.5M |
2013 Q2
1 quarter
|
|
412
Bunge Global
BG
$20.5B
| $36.2M | 0.06% |
476,844
+456,784
| +2,277% | +$34.6M |
2013 Q2
1 quarter
|
|
|
B
413
PUT
Barrick Mining
B
$66B
| $36.1M | 0.05% |
1,937,600
-313,800
| -14% | -$5.54M |
2013 Q2
1 quarter
|
|
414
Travel + Leisure Co
TNL
$3.86B
| $36M | 0.05% |
1,308,584
+879,711
| +205% | +$24.1M |
2013 Q2
1 quarter
|
|
|
PINC
415
DELISTED
Premier
PINC
| $36M | 0.05% |
+1,135,370
| New | +$35.6M |
2013 Q3
0 quarters
|
|
416
FNB Corp
FNB
$6.14B
| $35.8M | 0.05% |
2,955,270
-599,723
| -17% | -$7.53M |
2013 Q2
1 quarter
|
|
|
RPRX
417
DELISTED
Repros Therapeutics Inc.
RPRX
| $35.8M | 0.05% |
1,336,206
+655,384
| +96% | +$14M |
2013 Q2
1 quarter
|
|
418
Canadian Natural Resources
CNQ
$98.5B
| $35.6M | 0.05% |
2,343,743
-42,252
| -2% | -$634K |
2013 Q2
1 quarter
|
|
|
RHT
419
DELISTED
Red Hat Inc
RHT
| $35.6M | 0.05% |
770,771
+710,799
| +1,185% | +$36.1M |
2013 Q2
1 quarter
|
|
420
Cathay General Bancorp
CATY
$4.01B
| $35.4M | 0.05% |
1,515,777
-844
| -0.1% | -$19.5K |
2013 Q2
1 quarter
|
|
421
Intuitive Surgical
ISRG
$142B
| $35.3M | 0.05% |
845,136
+747,378
| +765% | +$33M |
2013 Q2
1 quarter
|
|
422
CALL
Micron Technology
MU
$1.24T
| $35.3M | 0.05% |
2,017,900
+188,500
| +10% | +$2.73M |
2013 Q2
1 quarter
|
|
423
CALL
Amgen
AMGN
$220B
| $35.2M | 0.05% |
314,200
+71,000
| +29% | +$7.7M |
2013 Q2
1 quarter
|
|
424
Zimmer Biomet
ZBH
$16.8B
| $35M | 0.05% |
438,346
+353,616
| +417% | +$27.8M |
2013 Q2
1 quarter
|
|
|
ENDP
425
DELISTED
Endo International plc
ENDP
| $34.9M | 0.05% |
769,051
+84,381
| +12% | +$3.39M |
2013 Q2
1 quarter
|
|
Similar funds
Citadel Advisors's Q3 2013 Portfolio in Review
As of Q3 2013, Citadel Advisors held 7,215 positions worth $65.7B, up 13% from $58.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Citadel Advisors withdrew a net $4.68B in Q3 2013, closing 505 positions and reducing 3,074 holdings. Its most notable exit was NEWS CORPORATION CL-A, an estimated $166M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, up from 41% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Citadel Advisors opened a new position in ELAN CORP ADS(RP1 ORD4IRISH PN worth $100M.
- Citadel Advisors's largest Q3 2013 buy was ELAN CORP ADS(RP1 ORD4IRISH PN: 6,448,014 shares worth $100M.
- Citadel Advisors added most to Philip Morris in Q3 2013, an estimated $245M increase.
- Citadel Advisors's biggest Q3 2013 reduction was Pfizer, cutting an estimated $245M.
- Citadel Advisors fully exited NEWS CORPORATION CL-A in Q3 2013, selling an estimated $166M.
- Citadel Advisors's ten largest holdings make up 12% of its $65.7B portfolio in Q3 2013.
- Citadel Advisors opened 734 new positions and closed 505 in Q3 2013.
- Citadel Advisors's portfolio value rose 13% quarter-over-quarter to $65.7B.
Based on Citadel Advisors's 13F filing for Q3 2013, filed 14 Nov 2013.